Janney Montgomery Scott LLC Charles River Laboratories International, Inc. Transaction History

Janney Montgomery Scott LLC

  • $35.8 Billion
  • Q3 2024

A detailed history of Janney Montgomery Scott LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 44,986 shares of CRL stock, worth $8.81 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
44,986
Previous 45,033 0.1%
Holding current value
$8.81 Million
Previous $9.3 Million 4.75%
% of portfolio
0.02%
Previous 0.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024
SELL
$187.96 - $245.29 $8,834 - $11,528
-47 Reduced 0.1%
44,986 $8.86 Million
Q2 2024

Jul 25, 2024
SELL
$206.39 - $268.73 $200,817 - $261,474
-973 Reduced 2.11%
45,033 $9.3 Million
Q1 2024

May 01, 2024
BUY
$203.52 - $273.43 $468,096 - $628,889
2,300 Added 5.26%
46,006 $12.5 Million
Q4 2023

Feb 07, 2024
SELL
$164.52 - $238.84 $201,537 - $292,579
-1,225 Reduced 2.73%
43,706 $10.3 Million
Q3 2023

Nov 08, 2023
SELL
$194.44 - $217.61 $131,247 - $146,886
-675 Reduced 1.48%
44,931 $8.81 Million
Q2 2023

Jul 26, 2023
BUY
$183.71 - $210.25 $642,617 - $735,454
3,498 Added 8.31%
45,606 $9.59 Million
Q1 2023

Apr 28, 2023
BUY
$191.89 - $259.92 $189,203 - $256,281
986 Added 2.4%
42,108 $8.5 Million
Q4 2022

Feb 01, 2023
SELL
$197.11 - $250.07 $491,986 - $624,174
-2,496 Reduced 5.72%
41,122 $8.96 Million
Q3 2022

Oct 25, 2022
BUY
$182.44 - $250.54 $37,582 - $51,611
206 Added 0.47%
43,618 $8.58 Million
Q2 2022

Aug 03, 2022
SELL
$204.13 - $302.4 $17,146 - $25,401
-84 Reduced 0.19%
43,412 $9.3 Million
Q1 2022

May 04, 2022
BUY
$255.51 - $362.11 $1.15 Million - $1.63 Million
4,499 Added 11.54%
43,496 $12.4 Million
Q4 2021

Jan 27, 2022
BUY
$351.38 - $448.68 $1.12 Million - $1.44 Million
3,201 Added 8.94%
38,997 $14.7 Million
Q3 2021

Oct 29, 2021
BUY
$372.64 - $458.3 $368,168 - $452,800
988 Added 2.84%
35,796 $14.8 Million
Q2 2021

Jul 26, 2021
BUY
$294.17 - $371.65 $521,269 - $658,563
1,772 Added 5.36%
34,808 $12.9 Million
Q1 2021

Apr 27, 2021
BUY
$249.67 - $299.48 $614,437 - $737,020
2,461 Added 8.05%
33,036 $9.58 Million
Q4 2020

Jan 25, 2021
BUY
$222.0 - $252.62 $485,958 - $552,985
2,189 Added 7.71%
30,575 $7.64 Million
Q3 2020

Nov 06, 2020
BUY
$175.56 - $226.45 $253,859 - $327,446
1,446 Added 5.37%
28,386 $6.43 Million
Q2 2020

Jul 23, 2020
BUY
$118.84 - $189.72 $388,606 - $620,384
3,270 Added 13.81%
26,940 $4.7 Million
Q1 2020

Apr 30, 2020
SELL
$98.9 - $178.34 $44,702 - $80,609
-452 Reduced 1.87%
23,670 $2.99 Million
Q4 2019

Jan 21, 2020
SELL
$126.05 - $152.76 $211,511 - $256,331
-1,678 Reduced 6.5%
24,122 $3.69 Million
Q3 2019

Oct 29, 2019
BUY
$125.07 - $143.67 $908,133 - $1.04 Million
7,261 Added 39.17%
25,800 $3.42 Million
Q2 2019

Jul 29, 2019
BUY
$123.4 - $148.55 $2,221 - $2,673
18 Added 0.1%
18,539 $2.63 Million
Q1 2019

Apr 30, 2019
BUY
$104.82 - $146.73 $161,422 - $225,964
1,540 Added 9.07%
18,521 $2.69 Million
Q4 2018

Feb 01, 2019
SELL
$105.09 - $137.23 $122,219 - $159,598
-1,163 Reduced 6.41%
16,981 $1.92 Million
Q3 2018

Nov 05, 2018
BUY
$112.11 - $134.54 $2.03 Million - $2.44 Million
18,144 New
18,144 $2.44 Million
Q1 2018

Apr 19, 2018
SELL
$98.19 - $115.2 $610,054 - $715,737
-6,213 Closed
0 $0
Q4 2017

Feb 14, 2018
SELL
$100.43 - $118.09 $21,492 - $25,271
-214 Reduced 3.33%
6,213 $680,000
Q3 2017

Nov 15, 2017
BUY
$96.72 - $109.26 $621,619 - $702,214
6,427
6,427 $694,000

Others Institutions Holding CRL

# of Institutions
696
Shares Held
52.3M
Call Options Held
259K
Put Options Held
463K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.96B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email